Belgian Society of Pediatric Heamatology-Oncology
0457.785.857 · rovalta.com · 28/09/2026
Belgian Society of Pediatric Heamatology-Oncology
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOBelgian Society of Pediatric Heamatology-Oncology is a Non-profit organization incorporated in 1995. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Woluwe-Saint-Lambert.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0457.785.857
- Incorporation
- 21/12/1995
- Legal form
- Non-profit organization
- Registered office
- Clos Chapelle-aux-Champs 30
1200 Woluwe-Saint-Lambert · BruxellesSee on map - Latest accounts
- 31/12/2025
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 664,7 k € | -19.4% | 824,9 k € | +15.3% | 715,4 k € | +21.5% | 588,6 k € | -0.8% | 593,6 k € |
| EBITDA | 28,6 k € | -20.4% | 35,9 k € | +21.1% | 29,7 k € | -32.0% | 43,6 k € | +310% | 10,6 k € |
| Operating result | 27,7 k € | -21.1% | 35,2 k € | +23.5% | 28,5 k € | -32.0% | 41,9 k € | +359% | 9,1 k € |
| Net result | 55 k € | -10.0% | 61,1 k € | +66.4% | 36,7 k € | -13.4% | 42,4 k € | +291% | 10,8 k € |
| Balance sheet | |||||||||
| Equity | 692,5 k € | +24.2% | 557,5 k € | +12.3% | 496,4 k € | +8.0% | 459,6 k € | +10.2% | 417,2 k € |
| Total assets | 3,4 M € | +9.6% | 3,1 M € | +9.4% | 2,9 M € | +13.2% | 2,5 M € | -6.9% | 2,7 M € |
| Cash | 4,3 k € | -92.1% | 54,1 k € | +520% | 8,7 k € | -98.0% | 442,9 k € | +109% | 211,5 k € |
| Debts | 267,6 k € | -14.0% | 311,2 k € | +40.7% | 221,2 k € | +70.7% | 129,6 k € | +43.0% | 90,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/202510 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Barbara DE MOERLOOSE | Chairman of the board of directors01/07/2025 → 30/06/2028Director07/06/2019 → 20/06/2025ended | ||
Benoît FLORKIN | Trésorier 01/07/2025 → 30/06/2028Director17/06/2022 → 20/06/2025ended | ||
Christophe CHANTRAIN | Vice-chairman of the board of directors01/07/2025 → 30/06/2028Director17/06/2022 → 20/06/2025ended | ||
Gabriel LEVY | Director01/07/2025 → 30/06/2028 | ||
Safiatou DAILLO | Director01/07/2025 → 30/06/2028 | ||
Sandra JACOBS | Director07/06/2019 → 30/06/2028 | ||
Toon VAN GENECHTEN | Secrétaire 01/07/2025 → 30/06/2028 | ||
An VAN DAMME | Managing director07/06/2019 → 20/06/2025Director07/06/2019 → 30/06/2022ended | ||
Christine DEVALCK | Director07/06/2019 → 20/06/2025 | ||
Koenraad NORGA | Director07/06/2019 → 20/06/2025 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Jutte VAN DER WERFF TEN BOSH | Director07/06/2019 → 30/06/2022 | ||
Marie-Françoise DRESSE | Director07/06/2019 → 30/06/2022 |
Other companies at this address
Clos Chapelle-aux-Champs 30 1200 Woluwe-Saint-Lambert| Company | CBE no. |
|---|---|
ABDA LILLY● Active | 0679.918.728 |
Acar'Up● Active | 0567.583.523 |
ACCELERATE● Active | 0733.539.041 |
ADGN● Active | 0682.872.377 |
ALLERINVEST● Active | 0644.917.069 |
astrohealth foundation● Active | 1011.965.663 |
BELBABY● Active | 0737.992.826 |
| 0414.282.743 | |
BIOPHARMATEK● Active | 0675.688.340 |
BRUSSELS LIFE SCIENCE INCUBATOR● Active | 0899.602.447 |
Cancer Drug Development Forum● Active | 0738.523.752 |
CELLTEST● Active | 0794.359.823 |
CENTRE CHAPELLE-AUX-CHAMPS● Active | 0460.875.209 |
| 0892.776.419 | |
| 0409.122.244 | |
| 0424.199.410 | |
| 0463.116.404 | |
Data for Healthcare Improvement● Active | 1008.075.864 |
| 0475.491.624 | |
| 0723.635.143 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2026 | 29/07/2025 | 26/06/2024 | 22/06/2023 | 22/06/2022 | 03/08/2021 |
| General meeting | 19/06/2026 | 20/06/2025 | 21/06/2024 | 09/06/2023 | 17/06/2022 | 11/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 19/06/2026 | 29/06/2026 | French | |
| Micro model | 31/12/2024 | 20/06/2025 | 29/07/2025 | French | |
| Micro model | 31/12/2023 | 21/06/2024 | 26/06/2024 | French | |
| Micro model | 31/12/2022 | 09/06/2023 | 22/06/2023 | French | |
| Micro model | 31/12/2021 | 17/06/2022 | 22/06/2022 | French | |
| Micro model | 31/12/2020 | 11/06/2021 | 03/08/2021 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202510 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Barbara DE MOERLOOSE | Chairman of the board of directors01/07/2025 → 30/06/2028Director07/06/2019 → 20/06/2025ended | ||
Benoît FLORKIN | Trésorier 01/07/2025 → 30/06/2028Director17/06/2022 → 20/06/2025ended | ||
Christophe CHANTRAIN | Vice-chairman of the board of directors01/07/2025 → 30/06/2028Director17/06/2022 → 20/06/2025ended | ||
Gabriel LEVY | Director01/07/2025 → 30/06/2028 | ||
Safiatou DAILLO | Director01/07/2025 → 30/06/2028 | ||
Sandra JACOBS | Director07/06/2019 → 30/06/2028 | ||
Toon VAN GENECHTEN | Secrétaire 01/07/2025 → 30/06/2028 | ||
An VAN DAMME | Managing director07/06/2019 → 20/06/2025Director07/06/2019 → 30/06/2022ended | ||
Christine DEVALCK | Director07/06/2019 → 20/06/2025 | ||
Koenraad NORGA | Director07/06/2019 → 20/06/2025 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Jutte VAN DER WERFF TEN BOSH | Director07/06/2019 → 30/06/2022 | ||
Marie-Françoise DRESSE | Director07/06/2019 → 30/06/2022 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates16/07/2026ADRESSE AUTRE QUE SIEGE, DEMISSIONS, NOMINATIONS
- Mandates16/07/2026ADRESSE AUTRE QUE SIEGE, DEMISSIONS, NOMINATIONS
- Mandates17/09/2025ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates17/09/2025DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates19/08/2022ONTSLAGEN - BENOEMINGEN
- Mandates19/08/2022DEMISSIONS, NOMINATIONS
- Mandates13/11/2020MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates13/11/2020SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Clos Chapelle-aux-Champs 30, 1200 Woluwe-Saint-LambertCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00210339 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Belgian Society of Pediatric Heamatology-OncologyCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00210339 |
Events
- 2025Annual accounts 202555 k €↓
- 2024Annual accounts 202461,1 k €↑
- 2023Annual accounts 202336,7 k €↓
- 2022Annual accounts 202242,4 k €↑
- 2021Annual accounts 202110,8 k €↑
- 2020Annual accounts 2020-15,2 k €
- 21/12/1995IncorporationNon-profit organization